Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
5.41
-0.18 (-3.22%)
At close: May 22, 2026, 4:00 PM EDT
5.45
+0.04 (0.74%)
After-hours: May 22, 2026, 7:59 PM EDT

Aspire Biopharma Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
----0.5
Cash & Short-Term Investments
----0.5
Inventory
0.370.25---
Other Current Assets
---0.080.6
Total Current Assets
7.121.310.150.081.1
Long-Term Investments
---19.9299
Other Long-Term Assets
----0.08
Total Assets
7.121.310.1519.98300.18
Accounts Payable
---0.150.18
Accrued Expenses
0.441.01---
Short-Term Debt
0.54.181.270.01-
Other Current Liabilities
1.351.39-0.240.12
Total Current Liabilities
2.296.581.270.40.3
Other Long-Term Liabilities
0.10.1--10.81
Total Long-Term Liabilities
0.10.1--10.81
Total Liabilities
2.396.671.270.411.12
Common Stock
00000
Additional Paid-in Capital
34.3520.881.2410.96-
Retained Earnings
----11.29-9.94
Total Common Shareholders' Equity
34.3520.881.24-0.32-9.94
Minority Interest
---19.9299
Shareholders' Equity
34.3520.881.2419.58289.07
Total Liabilities & Equity
7.121.310.1519.98300.18
Total Debt
0.54.181.270.010
Net Cash (Debt)
-0.5-4.18-1.27-0.010.5
Net Cash Per Share
-0.81-83.79-55.09-9.68388.62
Book Value
34.3520.881.24-0.32-9.94
Book Value Per Share
55.74419.0453.80-251.73-7766.76
Tangible Book Value
34.3520.881.24-0.32-9.94
Tangible Book Value Per Share
55.74419.0453.80-251.73-7766.76
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q